The new coronal vaccine, which is still waiting, is considered to be the key to the global restart. However, once a safe and effective vaccine is available, will the public be willing to actively vaccinate? China's novel coronavirus pneumonia vaccine has received the highest acceptance rate in Russia, and the lowest rate in China.
Novel coronavirus pneumonia (COVID-19) vaccine shilly Shally published in the top academic journal Nature Medicine, which is published online in the top academic journal, is likely to be a challenge to the global community population.
The research is entitled "a global survey of potential acceptance of a covid-19 vaccine". The corresponding author is Professor Jeffrey Lazarus of the Institute of global health in Barcelona, Spain, and the researchers are from Spain, the United States and the United Kingdom. Novel coronavirus pneumonia is the first public study to assess the global acceptance of the new crown pneumonia vaccine.
In June 2020, novel coronavirus pneumonia was investigated by Lazarus and colleagues in 13426 countries in 19 countries. Overall, 71.5% said they would be vaccinated if the vaccine proved to be safe and effective; 61.4% said they would if recommended by their employer.
The study noted that there were differences between regions, with acceptance rates ranging from nearly 90 per cent (China) to 55 per cent (Russia). The study noted that there were differences between regions. Countries with high acceptance rates are often Asian countries with high trust in central government (China, South Korea and Singapore), followed by middle-income countries such as Brazil, India and South Africa.
In addition, if the vaccination is compulsory by the employer rather than recommended, people's acceptance will also decline, which indicates that promoting vaccine rather than requiring vaccination may be a more effective strategy to achieve vaccination. Young people are more likely to accept vaccines recommended by their employers, while men are generally less willing to accept vaccines than women.
The research team is concerned about the low acceptance in some areas. The reasons for this hesitation over vaccines need to be understood and addressed, or global control of the epidemic could be delayed. They believe that the authorities must do more than simply declare that the vaccine is safe and effective. Acceptance building strategies need to address community-specific concerns and historical mistrust, and need to be sensitive to religious and philosophical beliefs.
The research team said that the government should issue clear and consistent recommendations, and reliable health promotion based on a full understanding of different cultural characteristics will be the key to influencing vaccination.